Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Biotech Industry Analysis

UpdatedMar 16, 2026
DataAggregated Company Financials
Companies5
  • 7D0.7%
  • 3M-19.3%
  • 1Y-2.0%
  • YTD-19.4%

The Biotech is pretty flat in the last 7 days, but Zealand Pharma has stood out, gaining 14%. In line with that, the industry has also been flat over the past 12 months. Looking forward, earnings are forecast to grow by 2.8% annually.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 16 Mar 2026DKK 138.2bDKK 39.8bDKK 14.0b10.2x9.8x3.5x
Wed, 11 Feb 2026DKK 164.5bDKK 40.2bDKK 18.8b6.2x8.7x4.1x
Fri, 09 Jan 2026DKK 178.5bDKK 40.7bDKK 19.0b6.4x9.4x4.4x
Sun, 07 Dec 2025DKK 176.4bDKK 40.7bDKK 19.1b6.1x9.3x4.3x
Tue, 04 Nov 2025DKK 167.9bDKK 39.2bDKK 16.9b12.9x9.9x4.3x
Thu, 02 Oct 2025DKK 175.7bDKK 38.8bDKK 16.7b12.6x10.5x4.5x
Sat, 30 Aug 2025DKK 147.5bDKK 38.9bDKK 16.8b11.2x8.8x3.8x
Mon, 28 Jul 2025DKK 137.1bDKK 26.9bDKK 7.3b13.2x18.8x5.1x
Wed, 25 Jun 2025DKK 121.9bDKK 27.1bDKK 7.4b10.6x16.5x4.5x
Fri, 23 May 2025DKK 128.7bDKK 28.0bDKK 7.9b10.5x16.3x4.6x
Sun, 20 Apr 2025DKK 124.4bDKK 27.3bDKK 7.7b11.2x16.2x4.6x
Tue, 18 Mar 2025DKK 143.4bDKK 27.3bDKK 7.7b12.2x18.7x5.2x
Thu, 13 Feb 2025DKK 151.2bDKK 26.0bDKK 4.7b15.2x32.2x5.8x
Sat, 11 Jan 2025DKK 170.6bDKK 26.0bDKK 4.7b17.9x36.3x6.6x
Mon, 09 Dec 2024DKK 173.1bDKK 26.0bDKK 4.7b17.8x36.9x6.6x
Wed, 06 Nov 2024DKK 172.1bDKK 25.5bDKK 5.5b20.2x31.4x6.8x
Fri, 04 Oct 2024DKK 175.3bDKK 25.5bDKK 5.5b21.6x32x6.9x
Sun, 01 Sep 2024DKK 203.5bDKK 25.5bDKK 5.5b25.4x37.2x8x
Tue, 30 Jul 2024DKK 201.3bDKK 24.8bDKK 5.6b18.6x35.7x8.1x
Thu, 27 Jun 2024DKK 183.5bDKK 24.8bDKK 5.6b17.6x32.6x7.4x
Sat, 25 May 2024DKK 175.6bDKK 24.8bDKK 5.6b18.5x31.2x7.1x
Mon, 22 Apr 2024DKK 178.7bDKK 23.9bDKK 5.0b18.9x35.5x7.5x
Wed, 20 Mar 2024DKK 189.8bDKK 23.9bDKK 5.0b19.3x37.8x7.9x
Fri, 16 Feb 2024DKK 172.9bDKK 22.8bDKK 4.2b23.5x41x7.6x
Sun, 14 Jan 2024DKK 182.0bDKK 23.3bDKK 4.2b25.5x43.7x7.8x
Tue, 12 Dec 2023DKK 178.5bDKK 23.3bDKK 4.2b26x42.9x7.7x
Thu, 09 Nov 2023DKK 170.8bDKK 22.7bDKK 4.3b21.7x39.8x7.5x
Sat, 07 Oct 2023DKK 193.2bDKK 22.0bDKK 4.7b22.7x40.8x8.8x
Mon, 04 Sep 2023DKK 200.9bDKK 22.0bDKK 4.7b23.8x42.5x9.1x
Wed, 02 Aug 2023DKK 203.7bDKK 19.5bDKK 4.4b35.2x46.2x10.4x
Fri, 30 Jun 2023DKK 195.0bDKK 19.5bDKK 4.4b40.9x44.3x10x
Sun, 28 May 2023DKK 214.9bDKK 19.5bDKK 4.4b42.1x48.8x11x
Tue, 25 Apr 2023DKK 211.6bDKK 17.9bDKK 3.5b33.1x59.8x11.8x
Thu, 23 Mar 2023DKK 191.2bDKK 17.9bDKK 3.5b29.9x53.9x10.7x
Price to Earnings Ratio

53.9x


Total Market Cap: DKK 191.2bTotal Earnings: DKK 3.5bTotal Revenue: DKK 17.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Biotech Industry Price to Earnings3Y Average 30.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 9.8x which is lower than its 3-year average PE of 30.2x.
  • The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 3.5x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 31% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-1.11%
Healthcare-2.40%
Biotech0.68%
Biotech0.68%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ZEAL Zealand PharmaDKK 268.204.8%
+DKK 875.5m		-53.6%PE2.9x
BIOPOR BioPortoDKK 0.904.1%
+DKK 17.3m		-39.4%PS12.1x
STRAP Strategic PartnersDKK 642.0010.7%
+DKK 2.6m		-9.7%PB1.5x

Latest News

GMAB
DKK 1,702.50
Genmab
7D
-1.3%
1Y
21.7%
BAVA
DKK 181.55
Bavarian Nordic
7D
-0.2%
1Y
9.3%
ZEAL
DKK 268.20
Zealand Pharma
7D
4.8%
1Y
-53.6%

ZEAL: Petrelintide Obesity Data And Pipeline Progress Will Support Future Upside

The updated analyst price target for Zealand Pharma moves lower to DKK 611 from about DKK 730, as analysts factor in reduced expectations for petrelintide's obesity opportunity, modestly higher risk assumptions, and a lower implied future P/E multiple, following a series of rating downgrades to Neutral or Hold. Analyst Commentary Recent research notes cluster around a more cautious stance on Zealand Pharma, with several firms shifting ratings to Neutral or Hold and setting price targets below the prior DKK 730 level.
BIOPOR
DKK 0.90
BioPorto
7D
4.1%
1Y
-39.4%
STRAP
DKK 642.00
Strategic Partners
7D
10.7%
1Y
-9.7%